Gold prices steady as traders assess Fed rate outlook after soft US data
Investing.com - Aptinyx reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Aptinyx announced earnings per share of $-0.230 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.237 on revenue of $0.00.
Aptinyx 's are down 48.09% and is trading at $0.315 , still down 91.62% from its 52 week high of $3.76 set on Thursday, February 17, 2022.
Aptinyx follows other major Healthcare sector earnings this month
Aptinyx's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar